← Back to Discover
Clarus Ventures, LLC
Period ended Sep 30, 2018 · Latest filing Nov 14, 2018
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2018: $425,478,000
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2018. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AvroBio Inc. · COM · 05455M100 · shares: $153,656,000
- Nanostring Technologies Inc. · COM · 63009R109 · shares: $71,962,000
- Sientra Inc. · COM · 82621J105 · shares: $65,211,000
- Forty Seven Inc · COM · 34983P104 · shares: $56,949,000
- Gritstone Oncology Inc · COM · 39868T105 · shares: $36,560,000
- Entasis Therapeutics Holdings Inc · COM · 293614103 · shares: $17,663,000
- Restoration Robotics Inc. · COM · 76133C103 · shares: $10,353,000
- VBI Vaccines Inc. · COM · 91822J103 · shares: $6,512,000
- ESSA Pharma Inc. · COM · 29668H708 · shares: $5,006,000
- Catabasis Pharmaceuticals Inc. · COM · 14875P107 · shares: $1,606,000
Reported holdings
10 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| AvroBio Inc. | COM | 05455M100 | — | 2,962,325 shares | $153,656,000 |
| Nanostring Technologies Inc. | COM | 63009R109 | — | 4,036,025 shares | $71,962,000 |
| Sientra Inc. | COM | 82621J105 | — | 2,730,765 shares | $65,211,000 |
| Forty Seven Inc | COM | 34983P104 | — | 3,816,951 shares | $56,949,000 |
| Gritstone Oncology Inc | COM | 39868T105 | — | 2,567,445 shares | $36,560,000 |
| Entasis Therapeutics Holdings Inc | COM | 293614103 | — | 1,623,405 shares | $17,663,000 |
| Restoration Robotics Inc. | COM | 76133C103 | — | 3,569,986 shares | $10,353,000 |
| VBI Vaccines Inc. | COM | 91822J103 | — | 2,691,042 shares | $6,512,000 |
| ESSA Pharma Inc. | COM | 29668H708 | — | 1,668,560 shares | $5,006,000 |
| Catabasis Pharmaceuticals Inc. | COM | 14875P107 | — | 2,008,192 shares | $1,606,000 |